Global Core Needle Biopsy Market, By Type (Full-Automated Core Needle Biopsy Device and Semi-Automated Core Needle Biopsy Device), Applications (Hospitals, Clinics and Others), Disease (Lung Cancer, Liver Cancer, Breast Cancer and Prostate Cancer), Range (14G- 18G, <14G and >18G), Distribution Channel (Direct Sales and Distributor), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Core Needle Biopsy Market
Rising cases of liver, prostate, breast and lung cancer have induced growth in the demand for core needle biopsy. Data Bridge Market Research analyses that the core needle biopsy will exhibit a CAGR of around 2.61% for the forecast period of 2021-2028.
A core needle biopsy is a process that involves the usage of a long and hollow tube-like needle that is used to extract a sample of tissue. The sample is next sent to the laboratory for testing purposes. Core needle biopsy is a standard way to diagnose various types of cancer. It is a safe and reliable procedure and has gained attraction in the global healthcare market.
The rising prevalence of cancer has led to the rise in demand for a core needle biopsy. Rising awareness about this medical procedure and its benefits has further induced growth in its demand. Rising expenditure on the healthcare infrastructure coupled with technological advancements especially in developing countries will create more lucrative opportunities for core needle biopsy market growth.
However, the risk of complications associated with biopsy will restrain the scope of growth for the core needle biopsy market. The high cost of biopsy devices will further slowdown the market growth rate. Lack of skilled and trained professionals will further pose a major challenge to the market growth.
This core needle biopsy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on core needle biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Core Needle Biopsy Market Scope and Market Size
The core needle biopsy market is segmented on the basis of type, applications, disease, range and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the type, the core needle biopsy market has been segmented into full- automated core needle biopsy device and semi- automated core needle biopsy device.
- Based on the applications, the core needle biopsy market has been segmented into hospitals, clinics and others.
- On the basis of disease, the core needle biopsy market is segmented into lung cancer, liver cancer, breast cancer and prostate cancer.
- On the basis of range, the core needle biopsy market is segmented into 14G- 18G, <14G and >18G.
- On the basis of distribution channel, the core needle biopsy market is segmented into direct sales and distributor.
Core Needle Biopsy Market Country Level Analysis
The core needle biopsy market is analysed and market size insights and trends are provided by country, type, applications, disease, range and distribution channel as referenced above.
The countries covered in the core needle biopsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the core needle biopsy market owing to the prevalence of sophisticated healthcare infrastructure, increased research and development proficiencies by the pharmaceutical companies and rapid adoption of new and better healthcare technologies. Asia-Pacific on the other hand is projected to score highest growth rate for the forecast period owing to rising expenditure to develop healthcare infrastructure, rising prevalence of cancer and rising geriatric population susceptible to cancer.
The country section of the core needle biopsy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Core needle biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the core needle biopsy market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Core Needle Biopsy Market Share Analysis
The core needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to core needle biopsy market.
The major players covered in the core needle biopsy market report are BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-